Purchase Order 75N91020P00942
Award Date 9/23/20
Potential Completion Date 9/22/21
Potential Value $591K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed price purchase order valued at approximately $945,000 to Leica Microsystems Inc. Leica Biosystems Division. The contract is for the acquisition of one Leica Stellaris 8 confocal and CARS (Coherent Anti-Stokes Raman Spectroscopy) and SRS (Stimulated Raman Spectroscopy) microscope to support research at the National Cancer Institute's Center for Cancer Research Neuro-Oncology...
- Leica Microsystems Inc., through its Leica Biosystems division, was awarded a $4,355 firm fixed-price Blanket Purchase Agreement (BPA) call by the National Cancer Institute on April 9, 2014, with an ultimate completion date of March 31, 2015. This contract, issued without set-aside designation, represents a task order against an existing BPA vehicle and was performed at the National Cancer Institute's facility in Bethesda, Maryland. Leica Microsystems, a subsidiary of Danaher Corporation, is a...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $349,867.78 delivery order contract to Leica Microsystems Inc. Leica Biosystems Division, a subsidiary of Danaher Corporation, to provide a Leica STELLARIS 5 white light laser system with installation and training services. The laser system and associated services will be delivered to the place of performance in Buffalo Grove, Illinois under a firm fixed price arrangement. The contract...
- The National Cancer Institute awarded a $202,490.42 firm fixed price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on June 13, 2024, for preventive maintenance services on one Leica Stellaris microscope under a Premium Care service agreement. The contract extends through June 12, 2029, and will be performed at Leica's facility in Riverwoods, Illinois. No small business set-aside designation was used in this competitive award to the original equipment manufacturer,...
- Leica Microsystems Inc., a subsidiary of Danaher Corporation, has been awarded a firm fixed price purchase order valued at $73,396 by the National Institutes of Health's National Institute of Child Health and Human Development. The contract is for a Leica SP5 confocal laser scanning microscope with AOTF, UV, and 405 nm solid state lasers to be located at the prime contractor's facility in Bannockburn, Illinois. The period of performance is from December 1, 2014 through November 30, 2016. No...
- Leica Microsystems Inc., a subsidiary of Danaher Corporation, has been awarded a $606,057 firm fixed-price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to deliver a confocal fluorescence imaging system. The system must meet the technical specifications outlined in the National Institute on Drug Abuse's solicitation numbered 75N95021Q00223, including components from Leica Microsystems. Delivery, installation, and training are...
- Leica Microsystems Inc., via its Leica Biosystems Division, has been awarded a $23,244.64 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute. To be performed in Bethesda, Maryland through January 31, 2025, the contract calls for unspecified services to support the agency's research programs. No set-aside designation was applied. Leica Microsystems maintains several Indefinite Delivery Indefinite Quantity...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $722,551 delivery order against Leica Microsystems Inc.'s Multiple Award Schedule contract. The delivery order is for a Leica Stellaris 8 laser scanning confocal and fluorescence lifetime microscope to be delivered to the agency's location in Riverwoods, Illinois by March 2024. As part of its mission to lead the nation's medical research efforts to prevent and cure cancer, the National...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $746,453.98 firm fixed price delivery order contract to Leica Microsystems Inc. Leica Biosystems Division. The contract was awarded against the contractor's Multiple Award Schedule contract vehicle and is for the purchase of one Leica STELLARIS STED confocal microscope and associated instrumentation in support of the National Institutes of Health National Cancer Institute...
- Leica Microsystems Inc. (Leica Biosystems division) received a $67,801.53 firm fixed-price purchase order from the National Cancer Institute (NCI) to provide maintenance services for two advanced confocal microscope systems: one Leica Basic Module TCS SP8 with LiaChroic and one Leica White Light Laser TCS SP8 X Falcon DMI8 WLL. These systems are located within NCI's Center for Cancer Research (CCR) Tumor Growth Microenvironment Branch (TGMB) laboratory in Bethesda, Maryland. The contract was...
Leica Microsystems Inc., a subsidiary of Danaher Corporation, has been awarded a firm fixed price purchase order valued at approximately $591,000 by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services. The contract calls for Leica to provide a Leica Stellaris 8 white light laser spectral confocal system in support of the Center for Cancer Research's Surgical Oncology Program and Metastasis Biology Section in Potomac, Maryland. No subcontractors or set aside designations were identified. The equipment will support the National Cancer Institute's research efforts related to cancer metastasis for the period of September 23, 2020 through September 22, 2021.
Generated 12/25/23, 3:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $0 | 9/25/20 | |
| Not listed | Not listed | $591.1k | 9/23/20 |